ABSTRACT

As the liver is the major site for drug metabolism, it is not surprising that drug toxicity and

adverse drug reactions would incite variable functional, histological, and ultrastructural

hepatic abnormalities (1-14). Up to 10% of patients with abnormal liver tests are found to

have drug-or toxin-induced hepatic injury, with the incidence rising to over 40% in patients

over the age of 50 (15). Drug-induced liver injury is estimated to occur in up to 1.4% of all

hospitalized patients and in from 2% to 5% of hospitalized patients with jaundice, and is

responsible for up to 15% to 20% of cases of intrahepatic cholestasis. In addition, up to one-half

of all cases of acute liver failure and 20% to 50% of cases of nonviral chronic hepatitis are

associated with drug-induced liver damage (11,12,16-22). The type of liver cell injury may be

intrinsic and dose dependent, whereby the mechanism may relate either to the formation of free

radicals or electrophilic intermediates, or to the production of active oxygen species, which, like

free radicals, lead to lipid peroxidation and direct distortion and destruction of liver cell

membranes (9,23-29). On the other hand, liver cell damage may be idiosyncratic and dose

independent, i.e., dependent on host susceptibility, and may be either immunologically or

metabolically mediated, with inflammatory mediators playing a role (12,16,28,30-33). A wide

variety of hepatic histological changes have been documented as secondary to drugs and toxins

(Table 1) (28,34,35); in addition, up to 1000 drugs and toxins have been implicated in causing

these histological changes (36,37). Even herbal medicines are now increasingly recognized as a

cause of liver injury (38). Although the morphological features are usually reversible with

discontinuation of the medication and toxin exposure, unfortunately, in severe (fulminant)

hepatitis and certain forms of chronic hepatitis, discontinuance of the drug does not alleviate

the sometimes drastic outcomes. This chapter divides drugs and toxins into the various

histological features seen on biopsy.